Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-29

FDA Approved: LIVMARLI — Original Application (Mirum Pharmaceuticals Inc.)

View source ↗

Summary

The FDA granted original approval for LIVMARLI (maralixibat chloride) through Mirum Pharmaceuticals' original NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LIVMARLI (Maralixibat chloride)

Snippet

ORIG AP for LIVMARLI (MARALIXIBAT CHLORIDE)